DCGI approves DRDO's anti-COVID drug helpful in faster recovery
Video Credit: ANI - Duration: 02:44s - Published
DCGI approves DRDO's anti-COVID drug helpful in faster recovery
Drugs Controller General of India (DCGI) on May 08 approved emergency use DRDO's anti-COVID drug which the agency said will be helpful in faster recovery of hospitalised patients.
While speaking to ANI, Institute of Nuclear Medicine and Allied Sciences (INMAS-DRDO) scientists spoken about drug 2-deoxy-D-glucose (2-DG).
The drug will be of immense benefit to the people suffering from COVID-19.
London Irish, Wasps and Worcester went out of business needing to repay more than £30m of Covid relief loans, a National Audit Office report says. BBC Sport
India has successfully test-fired its long-range hypersonic missile, joining a select group of countries including Russia and China. The missile, launched by the Defence Research and Development Organisation (DRDO) on November 16, 2024, can reach speeds over Mach 5 (more than 6,174 km/h) and target both sea and land-based objectives. This achievement underscores India's growing stature as a global military power.
#IndiaHypersonic #DRDO #IndianDefense #MilitaryTechnology #HypersonicMissile #Mach5 #StrategicAdvantage #SelfReliance #GlobalDefense #IndiaRising #Oneindia #OneindiaNews
~HT.178~PR.362~ED.155~GR.124~
The first batch of anti-Covid oral drug 2-DG, developed by the DRDO, was released on Monday by Defence Minister Rajnath Singh and Health Minister Harsh Vardhan. Even as the country is reeling under..
Institute of Nuclear Medicine and Allied Sciences-DRDO scientist Dr Sudhir Chandna on drug 2-deoxy-D-glucose (2-DG) while speaking to ANI informed about the observations of the medicine's clinical..
From DCGI approving new anti-Covid drug, to health ministry issues new rules for hospital admissions, here are the top updates on the coronavirus. DCGI approved a new anti-Covid oral drug, which has..
Credit: HT Digital Content Duration: 03:24Published